1 yr target is 11.60, more than twice the current price. Summer is very cruel to biotech investors, particularly to those in companies whose profitable years are 1 year away.http://finance.yahoo.com/q/bc?s=BMRN&t=1d
Are you asking "why will this stock double in a year?" or are you telling us "why this stock will double in a year"? Either way, to suggest that biotechnology is a seasonal business is insane!
Why is biotech seasonal ? Lack of water to run trials & experiments ?
Maybe no summer conferences = no hypeprobably just spurious data mining though.
Look up the historical charts for osip, imcl, chir, biib, not to mention dna, gild, and amgn. Patience.